- Home
- ATOS vs ATLX Comparison
ATOS vs ATLX Comparison
Compare ATOS & ATLX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ATOS
- ATLX
- Stock Information
- Founded
- ATOS 2009
- ATLX 2011
- Country
- ATOS United States
- ATLX Brazil
- Employees
- ATOS N/A
- ATLX N/A
- Industry
- ATOS Biotechnology: Pharmaceutical Preparations
- ATLX Mining & Quarrying of Nonmetallic Minerals (No Fuels)
- Sector
- ATOS Health Care
- ATLX Industrials
- Exchange
- ATOS Nasdaq
- ATLX Nasdaq
- Market Cap
- ATOS 112.7M
- ATLX 111.7M
- IPO Year
- ATOS 2012
- ATLX N/A
- Fundamental
- Price
- ATOS $1.01
- ATLX $6.01
- Analyst Decision
- ATOS Strong Buy
- ATLX Strong Buy
- Analyst Count
- ATOS 3
- ATLX 1
- Target Price
- ATOS $6.25
- ATLX $19.00
- AVG Volume (30 Days)
- ATOS 762.2K
- ATLX 784.0K
- Earning Date
- ATOS 11-11-2025
- ATLX 11-07-2025
- Dividend Yield
- ATOS N/A
- ATLX N/A
- EPS Growth
- ATOS N/A
- ATLX N/A
- EPS
- ATOS N/A
- ATLX N/A
- Revenue
- ATOS N/A
- ATLX $350,003.00
- Revenue This Year
- ATOS N/A
- ATLX $22,084.55
- Revenue Next Year
- ATOS N/A
- ATLX N/A
- P/E Ratio
- ATOS N/A
- ATLX N/A
- Revenue Growth
- ATOS N/A
- ATLX N/A
- 52 Week Low
- ATOS $0.55
- ATLX $3.54
- 52 Week High
- ATOS $1.66
- ATLX $11.89
- Technical
- Relative Strength Index (RSI)
- ATOS 77.26
- ATLX 62.74
- Support Level
- ATOS $0.81
- ATLX $4.60
- Resistance Level
- ATOS $0.90
- ATLX $5.83
- Average True Range (ATR)
- ATOS 0.04
- ATLX 0.47
- MACD
- ATOS 0.02
- ATLX 0.12
- Stochastic Oscillator
- ATOS 83.33
- ATLX 97.74
About ATOS Atossa Therapeutics Inc.
Atossa Therapeutics Inc is a clinical stage biopharmaceutical company developing proprietary medicines in areas of unmet medical need in oncology. It focuses on the development of novel therapeutics and delivery methods for the treatment of breast cancer, other breast conditions and COVID-19. The company's drug under development for breast cancer and other breast conditions is Endoxifen. Its two COVID-19 drugs under development are AT-H201, to improve lung function of moderate to severely ill, hospitalized COVID-19 patients by inhalation; and AT-301, a nasal spray for COVID-19 patients for at-home use.
About ATLX Atlas Lithium Corporation
Atlas Lithium Corp is a mineral exploration and development company with lithium projects and exploration properties in other critical and battery minerals, including nickel, rare earth, graphite, and titanium, to power the increased demand for electrification. Its focus is on developing its hard-rock lithium project Minas Gerais Lithium Project located in Minas Gerais State in Brazil. The company intends to produce and sell lithium concentrate, a key ingredient for the battery supply chain. It intends to mine and then process its lithium-containing ore to produce lithium concentrate (also known as spodumene concentrate), a key ingredient for the battery supply chain.